DP

Dante D. Podesto

TI Theravance Biopharma R&D Ip: 6 patents #41 of 116Top 40%
📍 Modesto, CA: #84 of 548 inventorsTop 20%
🗺 California: #93,399 of 386,348 inventorsTop 25%
Overall (All Time): #785,359 of 4,157,543Top 20%
6
Patents All Time

Issued Patents All Time

Showing 1–6 of 6 patents

Patent #TitleCo-InventorsDate
12358931 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl) propanenitrile as a JAK kinase inhibitor Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Gary E. L. Brandt, Melissa Fleury +1 more 2025-07-15
11780852 Methods for treating Crohn's disease using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Ryan Hudson, Jennifer Kozak, Xiaojun Huang, Venkat R. Thalladi 2023-10-10
11110095 Pyrimidine compounds as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Melissa Fleury, Paul R. Fatheree, Anne-Marie Beausoleil +1 more 2021-09-07
10947254 Methods for treating ulcerative colitis using 3-((1R,3s,5S)-3-((7-((5-methyl-1H-pyrazol-3-yl)amino)-1,6-naphthyridin-5-yl)amino)-8-azabicyclo[3.2.1]octan-8-yl)propanenitrile Ryan Hudson, Jennifer Kozak, Xiaojun Huang, Venkat R. Thalladi 2021-03-16
10028960 Pyrimidine compounds as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Melissa Fleury, Paul R. Fatheree, Anne-Marie Beausoleil 2018-07-24
9725470 Substituted naphthyridines as JAK kinase inhibitors Ryan Hudson, Jennifer Kozak, Paul R. Fatheree, Gary E. L. Brandt, Melissa Fleury +1 more 2017-08-08